Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC (IRRADIATE-Lung)
A Phase II Trial of Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLC
Sponsor: NYU Langone Health
Terminated
Terminated due to insufficient enrollment.
A PHASE2 clinical study on NSCLC Stage IV, this trial is terminated or withdrawn. The trial is conducted by NYU Langone Health and has accumulated 8 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Aug 2025 — Present [monthly]
Terminated PHASE2
-
Jun 2025 — Aug 2025 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
Nov 2024 — Jun 2025 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
▶ Show 3 earlier versions
-
Feb 2024 — Jul 2024 [monthly]
Recruiting PHASE2
-
Mar 2023 — Feb 2024 [monthly]
Recruiting PHASE2
-
Feb 2023 — Mar 2023 [monthly]
Recruiting PHASE2
First recorded
Jan 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- NYU Langone Health
For direct contact, visit the study record on ClinicalTrials.gov .